Linoleic Acid

Linoleic Acid

SCHEMBL887212

CCCCCC=CC/C=C\CCCCCCCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 1.00
PPARD Q03181 6/20 1.00
PPARA Q07869 6/20 1.00
ALDH1A1 P00352 5/20 1.00
F7 P08709 5/20 1.00
F3 P13726 5/20 1.00
FABP4 P15090 4/20 1.00
HSD17B10 Q99714 4/20 1.00
FFAR1 O14842 3/20 1.00
PTGS1 P23219 3/20 1.00
LMNA P02545 3/20 1.00
CYP19A1 P11511 3/20 1.00
ALOX15 P16050 3/20 1.00
NR4A2 P43354 3/20 1.00
KDM4E B2RXH2 2/20 1.00
CYP3A4 P08684 2/20 1.00
HPGD P15428 2/20 1.00
AKR1C3 P42330 2/20 1.00
TDP1 Q9NUW8 2/20 1.00
DUSP3 P51452 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16685715 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL15880317 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
Linoleic Acid SCHEMBL20856202 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL22498259 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL22498256 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
Arachidic Acid SCHEMBL20528087 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
Linoleic Acid SCHEMBL25294178 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL22498258 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
Dihomo-Gamma-Linolenic Acid SCHEMBL20656585 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL21411004 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 581 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025234951-A1 PROCESS FOR THE PRODUCTION OF POLYURETHANE CATALYST EGE Kimya San. ve Tic. A.S. (TR) 2025-11-13 WO claimed
CN-106998743-B Compounds for modulating fatty acid receptor activity and pet food comprising the same 马斯公司 2024-05-24 CN claimed
CN-118048052-A Water-soluble dye microsphere, preparation method and application thereof 江南大学 2024-05-17 CN claimed
CN-118010887-A Method for analyzing fatty acid in grease 湘潭大学 2024-05-10 CN claimed
CN-117571864-A Method for detecting fatty acid content 中国计量科学研究院 2024-02-20 CN claimed
CN-117461638-A Lizus natural enemy attractant composition for preventing and controlling whitefly pests and application thereof 浙江大学 2024-01-30 CN claimed
CN-117285980-A Alternaria sibirica kernel oil and extraction method and application thereof 广西壮族自治区农业科学院 2023-12-26 CN claimed
EP-4114425-A1 COMPOSITIONS DERIVED FROM SALVIA HISPANICA SEEDS Signum Biosciences, Inc. (US) 2023-01-11 EP claimed
CN-115572644-A Liquid composition for improving glossiness of hard surface and hard surface detergent 赞宇科技集团股份有限公司 2023-01-06 CN claimed
EP-3383380-B1 LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE BIOZEP AS (NO) 2023-01-04 EP claimed
EP-2120960-A2 NOVEL ß-LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co.KG (DE) 2009-11-25 EP claimed
WO-2009103991-A2 INSECT ATTRACTANTS AND THEIR USE IN METHODS OF INSECT CONTROL KEELE UNIVERSITY (GB) 2009-08-27 WO claimed
CN-101489523-A Cosmetic or dermatological preparations comprising n-acetylcysteine ZAMBON SPA (IT) 2009-07-22 CN claimed
WO-2009073931-A1 NUTRACEUTICAL COMPOSITION AND METHODS OF USE DACY TECH PTY LTD (AU) 2009-06-18 WO claimed
WO-2009073930-A1 NUTRACEUTICAL COMPOSITION AND METHODS OF USE DACY TECH PTY LTD (AU) 2009-06-18 WO claimed
WO-2008092928-A2 NOVEL ß-LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF DRITTE PATENTPORTFOLIO BETEILIGUNGSGESELLSCHAFT MBH & CO. KG (DE) 2008-08-07 WO claimed
US-20070101902-A1 Low VOC solvent useful with paints and coatings SOY TECHNOLOGIES, LLC 2007-05-10 US claimed
US-20060013906-A1 Anti-helicobacter activity of celery seed extract RAINSFORD KIM D 2006-01-19 US claimed
EP-1511504-A1 ANTI-HELICOBACTER ACTIVITY OF CELERY SEED EXTRACT Sheffield Hallam University (GB) 2005-03-09 EP claimed
WO-2003099303-A1 ANTI-HELICOBACTER ACTIVITY OF CELERY SEED EXTRACT SHEFFIELD, HALLAM UNIVERSITY (GB) 2003-12-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060013906-A1 Anti-helicobacter activity of celery seed extract CEL, CTSA, HUNK PPARG 1599/4885PPARD 1499/4885PPARA 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.